Logo image of MPX

MARINE PRODUCTS CORP (MPX) Stock Fundamental Analysis

NYSE:MPX - New York Stock Exchange, Inc. - US5684271084 - Common Stock - Currency: USD

8.86  +0.01 (+0.11%)

After market: 8.86 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MPX. MPX was compared to 31 industry peers in the Leisure Products industry. MPX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MPX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

MPX had positive earnings in the past year.
In the past year MPX had a positive cash flow from operations.
In the past 5 years MPX has always been profitable.
MPX had a positive operating cash flow in each of the past 5 years.
MPX Yearly Net Income VS EBIT VS OCF VS FCFMPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.80%, MPX belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
MPX's Return On Equity of 10.62% is amongst the best of the industry. MPX outperforms 87.10% of its industry peers.
MPX has a better Return On Invested Capital (9.28%) than 80.65% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MPX is significantly above the industry average of 7.11%.
The last Return On Invested Capital (9.28%) for MPX is well below the 3 year average (20.95%), which needs to be investigated, but indicates that MPX had better years and this may not be a problem.
Industry RankSector Rank
ROA 7.8%
ROE 10.62%
ROIC 9.28%
ROA(3y)18.3%
ROA(5y)18.46%
ROE(3y)23.86%
ROE(5y)24.6%
ROIC(3y)20.95%
ROIC(5y)21.9%
MPX Yearly ROA, ROE, ROICMPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

MPX has a better Profit Margin (6.02%) than 90.32% of its industry peers.
MPX's Profit Margin has declined in the last couple of years.
MPX has a Operating Margin of 6.49%. This is amongst the best in the industry. MPX outperforms 80.65% of its industry peers.
MPX's Operating Margin has declined in the last couple of years.
MPX has a worse Gross Margin (18.81%) than 74.19% of its industry peers.
MPX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.49%
PM (TTM) 6.02%
GM 18.81%
OM growth 3Y-14.4%
OM growth 5Y-8.08%
PM growth 3Y-9.54%
PM growth 5Y-5.61%
GM growth 3Y-5.68%
GM growth 5Y-2.99%
MPX Yearly Profit, Operating, Gross MarginsMPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

8

2. Health

2.1 Basic Checks

MPX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MPX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MPX has more shares outstanding
There is no outstanding debt for MPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MPX Yearly Shares OutstandingMPX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MPX Yearly Total Debt VS Total AssetsMPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 7.21 indicates that MPX is not in any danger for bankruptcy at the moment.
MPX has a better Altman-Z score (7.21) than 87.10% of its industry peers.
There is no outstanding debt for MPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.21
ROIC/WACC1.02
WACC9.14%
MPX Yearly LT Debt VS Equity VS FCFMPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.96 indicates that MPX has no problem at all paying its short term obligations.
MPX has a Current ratio of 2.96. This is in the better half of the industry: MPX outperforms 64.52% of its industry peers.
MPX has a Quick Ratio of 1.81. This is a normal value and indicates that MPX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.81, MPX is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 1.81
MPX Yearly Current Assets VS Current LiabilitesMPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

The earnings per share for MPX have decreased strongly by -48.72% in the last year.
MPX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.79% yearly.
The Revenue for MPX has decreased by -21.97% in the past year. This is quite bad
The Revenue has been decreasing by -4.13% on average over the past years.
EPS 1Y (TTM)-48.72%
EPS 3Y-11.21%
EPS 5Y-9.79%
EPS Q2Q%-14.29%
Revenue 1Y (TTM)-21.97%
Revenue growth 3Y-7.41%
Revenue growth 5Y-4.13%
Sales Q2Q%-2.66%

3.2 Future

The Earnings Per Share is expected to grow by 1.11% on average over the next years.
Based on estimates for the next years, MPX will show a small growth in Revenue. The Revenue will grow by 7.95% on average per year.
EPS Next Y-18.38%
EPS Next 2Y1.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.11%
Revenue Next 2Y7.95%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MPX Yearly Revenue VS EstimatesMPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
MPX Yearly EPS VS EstimatesMPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

MPX is valuated rather expensively with a Price/Earnings ratio of 22.15.
70.97% of the companies in the same industry are more expensive than MPX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.87, MPX is valued at the same level.
MPX is valuated rather expensively with a Price/Forward Earnings ratio of 17.69.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MPX indicates a somewhat cheap valuation: MPX is cheaper than 61.29% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, MPX is valued a bit cheaper.
Industry RankSector Rank
PE 22.15
Fwd PE 17.69
MPX Price Earnings VS Forward Price EarningsMPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MPX is valued a bit cheaper than the industry average as 61.29% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, MPX is valued a bit cheaper than the industry average as 64.52% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.01
EV/EBITDA 14.81
MPX Per share dataMPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

MPX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.11%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.33%, MPX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.22, MPX pays a better dividend. On top of this MPX pays more dividend than 96.77% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, MPX pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.33%

5.2 History

On average, the dividend of MPX grows each year by 16.89%, which is quite nice.
MPX has been paying a dividend for at least 10 years, so it has a reliable track record.
MPX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)16.89%
Div Incr Years4
Div Non Decr Years4
MPX Yearly Dividends per shareMPX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

144.60% of the earnings are spent on dividend by MPX. This is not a sustainable payout ratio.
The dividend of MPX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP144.6%
EPS Next 2Y1.11%
EPS Next 3YN/A
MPX Yearly Income VS Free CF VS DividendMPX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M
MPX Dividend Payout.MPX Dividend Payout, showing the Payout Ratio.MPX Dividend Payout.PayoutRetained Earnings

MARINE PRODUCTS CORP

NYSE:MPX (8/15/2025, 8:04:00 PM)

After market: 8.86 0 (0%)

8.86

+0.01 (+0.11%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-22 2025-10-22
Inst Owners15.86%
Inst Owner Change0%
Ins Owners4.51%
Ins Owner Change0.17%
Market Cap310.10M
Analysts45
Price Target8.16 (-7.9%)
Short Float %2.83%
Short Ratio10.67
Dividend
Industry RankSector Rank
Dividend Yield 6.33%
Yearly Dividend1.26
Dividend Growth(5Y)16.89%
DP144.6%
Div Incr Years4
Div Non Decr Years4
Ex-Date08-11 2025-08-11 (0.14)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.9%
Min EPS beat(2)-24.8%
Max EPS beat(2)-0.99%
EPS beat(4)2
Avg EPS beat(4)32.41%
Min EPS beat(4)-24.8%
Max EPS beat(4)128.48%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.25%
Min Revenue beat(2)-11.36%
Max Revenue beat(2)-1.14%
Revenue beat(4)1
Avg Revenue beat(4)-3.35%
Min Revenue beat(4)-11.36%
Max Revenue beat(4)2.26%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 22.15
Fwd PE 17.69
P/S 1.38
P/FCF 20.01
P/OCF 16.36
P/B 2.44
P/tB 2.51
EV/EBITDA 14.81
EPS(TTM)0.4
EY4.51%
EPS(NY)0.5
Fwd EY5.65%
FCF(TTM)0.44
FCFY5%
OCF(TTM)0.54
OCFY6.11%
SpS6.41
BVpS3.64
TBVpS3.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.8%
ROE 10.62%
ROCE 11.29%
ROIC 9.28%
ROICexc 15.2%
ROICexgc 15.96%
OM 6.49%
PM (TTM) 6.02%
GM 18.81%
FCFM 6.91%
ROA(3y)18.3%
ROA(5y)18.46%
ROE(3y)23.86%
ROE(5y)24.6%
ROIC(3y)20.95%
ROIC(5y)21.9%
ROICexc(3y)32.66%
ROICexc(5y)31.62%
ROICexgc(3y)33.97%
ROICexgc(5y)33.01%
ROCE(3y)25.47%
ROCE(5y)26.62%
ROICexcg growth 3Y-20.57%
ROICexcg growth 5Y-18.72%
ROICexc growth 3Y-20.57%
ROICexc growth 5Y-18.41%
OM growth 3Y-14.4%
OM growth 5Y-8.08%
PM growth 3Y-9.54%
PM growth 5Y-5.61%
GM growth 3Y-5.68%
GM growth 5Y-2.99%
F-Score5
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 116.12%
Cap/Sales 1.54%
Interest Coverage 250
Cash Conversion 108.11%
Profit Quality 114.68%
Current Ratio 2.96
Quick Ratio 1.81
Altman-Z 7.21
F-Score5
WACC9.14%
ROIC/WACC1.02
Cap/Depr(3y)238.99%
Cap/Depr(5y)178.67%
Cap/Sales(3y)1.75%
Cap/Sales(5y)1.31%
Profit Quality(3y)127.39%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.72%
EPS 3Y-11.21%
EPS 5Y-9.79%
EPS Q2Q%-14.29%
EPS Next Y-18.38%
EPS Next 2Y1.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.97%
Revenue growth 3Y-7.41%
Revenue growth 5Y-4.13%
Sales Q2Q%-2.66%
Revenue Next Year3.11%
Revenue Next 2Y7.95%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.36%
EBIT growth 3Y-20.74%
EBIT growth 5Y-11.88%
EBIT Next Year20.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.82%
FCF growth 3YN/A
FCF growth 5Y-4.62%
OCF growth 1Y-74.03%
OCF growth 3Y300.39%
OCF growth 5Y-2.74%